North American Palladium (PAL) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Share on StockTwits

North American Palladium (NYSE:PAL) posted its quarterly earnings results on Wednesday. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.01, AnalystRatings.NET reports.

Several analysts have recently commented on the stock. Analysts at Zacks upgraded shares of North American Palladium from an “underperform” rating to a “neutral” rating in a research note on Tuesday, July 22nd. They now have a $0.30 price target on the stock. Two investment analysts have rated the stock with a sell rating and four have assigned a hold rating to the company. The company has a consensus rating of “Hold” and an average price target of $0.30.

Shares of North American Palladium (NYSE:PAL) traded down 6.19% during mid-day trading on Wednesday, hitting $0.2897. 2,641,892 shares of the company’s stock traded hands. North American Palladium has a 52 week low of $0.23 and a 52 week high of $1.27. The stock’s 50-day moving average is $0.31 and its 200-day moving average is $0.36. The company’s market cap is $105.1 million.

North American Palladium Ltd. (NYSE:PAL) is a precious metals producer that has been operating its flagship Lac des Iles mine (LDI) located in Ontario, Canada.

Receive News & Ratings for North American Palladium Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for North American Palladium Ltd and related companies with Analyst Ratings Network's FREE daily email newsletter.

Latest News

Washington Real Estate Investment Trust Given Consensus Rating of “Hold” by Brokerages
Washington Real Estate Investment Trust Given Consensus Rating of “Hold” by Brokerages
Qunar Cayman Islands Receives Consensus Rating of “Buy” from Analysts
Qunar Cayman Islands Receives Consensus Rating of “Buy” from Analysts
Neurocrine Biosciences Given Average Rating of “Buy” by Brokerages
Neurocrine Biosciences Given Average Rating of “Buy” by Brokerages
Astoria Financial Corp Given Consensus Recommendation of “Hold” by Analysts
Astoria Financial Corp Given Consensus Recommendation of “Hold” by Analysts
KBR Receives Average Recommendation of “Buy” from Analysts
KBR Receives Average Recommendation of “Buy” from Analysts
Vanguard Natural Resources Given Consensus Recommendation of “Hold” by Analysts
Vanguard Natural Resources Given Consensus Recommendation of “Hold” by Analysts


Leave a Reply

 
Advertisement
Advertisement
© 2006-2014 Mideast Time.